2486. Clinical Outcomes of Patients Treated with Dolutegravir Functional Monotherapy or Dolutegravir plus an Active Non-cytosine Nucleoside Analog: A Retrospective Observational Cohort Study of Treatment-Experienced Patients

BACKGROUND: Dual dolutegravir (DTG)-containing regimens (DCRs) are currently approved for the treatment of antiretroviral (ARV) naïve and experienced patients with HIV-1 infection. DTG monotherapy has resulted in unacceptable rates of virologic failure and subsequent development of DTG resistance. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Rolle, Charlotte-Paige M, Bryant, Beth, Tucker, Colton J, Camila Castro, Maria, Nguyen, Vu, Hinestrosa, Federico, DeJesus, Edwin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809811/
http://dx.doi.org/10.1093/ofid/ofz360.2164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809811/
http://dx.doi.org/10.1093/ofid/ofz360.2164

Ejemplares similares